Literature DB >> 24982351

Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.

Toshihide Sakurai1, Hiroshi Okumura2, Masataka Matsumoto1, Yasuto Uchikado1, Tetsuhiro Owaki1, Yoshiaki Kita1, Tetsuro Setoyama1, Itaru Omoto1, Yuko Kijima1, Sumiya Ishigami1, Shoji Natsugoe1.   

Abstract

BACKGROUND: Angiogenic molecular markers such as vascular endothelial growth factor and tumor microvessel density reflect prognosis of human cancers. The present study clarified the usefulness of endothelial marker endoglin (CD 105) by assessing microvessel density in esophageal squamous cell carcinoma (ESCC).
MATERIALS AND METHODS: We immunohistochemically investigated CD105, CD31, and vascular endothelial growth factor-A VEGF-A expression in primary esophageal squamous cell carcinoma specimens from 142 patients.
RESULTS: Microvessel density was 35.9±21.2 for CD105 and 46.3±25.4 for CD31. CD105 microvessel density was significantly associated with tumor length, tumor invasion depth, lymph node metastasis, stage, lymphatic invasion, venous invasion, and VEGF-A expression; its correlation with almost all clinicopathological parameters was stronger than CD31 microvessel density. And significantly better prognosis was achieved in patients with low, compared to high CD105, microvessel density.
CONCLUSION: CD105 microvessel density reflected the degree of angiogenesis and prognosis in patients with esophageal squamous cell carcinoma. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  CD31; Endoglin (CD105); esophageal cancer; vascular endothelial growth factor

Mesh:

Substances:

Year:  2014        PMID: 24982351

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Expression profile of Twist, vascular endothelial growth factor and CD34 in patients with different phases of osteosarcoma.

Authors:  Pengfei Lei; Dengfeng Ding; Jie Xie; Long Wang; Qiande Liao; Yihe Hu
Journal:  Oncol Lett       Date:  2015-05-20       Impact factor: 2.967

2.  Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review.

Authors:  Vincent Q Sier; Joost R van der Vorst; Paul H A Quax; Margreet R de Vries; Elham Zonoobi; Alexander L Vahrmeijer; Ilona A Dekkers; Lioe-Fee de Geus-Oei; Anke M Smits; Weibo Cai; Cornelis F M Sier; Marie José T H Goumans; Lukas J A C Hawinkels
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

3.  Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling.

Authors:  Xiaoling Zhang; Yan Zhang; Yanan Jia; Tingting Qin; Cuicui Zhang; Yueya Li; Chengmou Huang; Zhujun Liu; Jing Wang; Kai Li
Journal:  Cancer Biol Med       Date:  2020-05-15       Impact factor: 4.248

4.  A comparison of CD105 and CD31 expression in tumor vessels of hepatocellular carcinoma by tissue microarray and flow cytometry.

Authors:  Hongyan Qian; Liping Yang; Wenjing Zhao; Haizhen Chen; Song He
Journal:  Exp Ther Med       Date:  2018-08-01       Impact factor: 2.447

5.  CD105 Is Expressed in Ovarian Cancer Precursor Lesions and Is Required for Metastasis to the Ovary.

Authors:  Shoumei Bai; Wanhong Zhu; Lan Coffman; Anda Vlad; Lauren E Schwartz; Esther Elishaev; Ronny Drapkin; Ronald J Buckanovich
Journal:  Cancers (Basel)       Date:  2019-11-02       Impact factor: 6.639

6.  Immunohistochemical Evaluation of Angiogenesis and Cell Proliferation in Tongue Squamous Cell Carcinoma.

Authors:  Maryam Khalili; Nazanin Mahdavi; Razieh Beheshti; Fereshteh Baghai Naini
Journal:  J Dent (Tehran)       Date:  2015-11

7.  Anti-Human Endoglin (hCD105) Immunotoxin-Containing Recombinant Single Chain Ribosome-Inactivating Protein Musarmin 1.

Authors:  Begoña Barriuso; Pilar Antolín; F Javier Arias; Alessandra Girotti; Pilar Jiménez; Manuel Cordoba-Diaz; Damián Cordoba-Diaz; Tomás Girbés
Journal:  Toxins (Basel)       Date:  2016-06-10       Impact factor: 4.546

8.  Prognostic value of endoglin-assessed microvessel density in cancer patients: a systematic review and meta-analysis.

Authors:  Jinguo Zhang; Lingyun Zhang; Qunbo Lin; Weimin Ren; Guoxiong Xu
Journal:  Oncotarget       Date:  2017-12-21

9.  Assessing Microcirculation in Resectable Oesophageal Squamous Cell Carcinoma with Dynamic Contrast-enhanced MRI for Identifying Primary tumour and Lymphatic Metastasis.

Authors:  Yan-Li Chen; Yu Jiang; Tian-Wu Chen; Rui Li; Xiao-Ming Zhang; Fan Chen; Lan Wu; Jing Ou; Jian-Qiong Yang
Journal:  Sci Rep       Date:  2019-01-15       Impact factor: 4.379

10.  Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis.

Authors:  Claudia Ollauri-Ibáñez; Elena Núñez-Gómez; Cristina Egido-Turrión; Laura Silva-Sousa; Elena Díaz-Rodríguez; Alicia Rodríguez-Barbero; José M López-Novoa; Miguel Pericacho
Journal:  Angiogenesis       Date:  2020-01-03       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.